Concepedia

Author

Mirza I. Rahman

Ortho Clinical Diagnostics (United States)

Also Known As

M I Rahman, M. I. Rahman, MIRZA I RAHMAN, Mirza I Rahman, Mirza I. Rahman, Mirza Rahman

27

Publications

450

Citations

10

H-Index

24

Concepts

All Affiliations

Ortho Clinical Diagnostics (United States)Otsuka (United States)Pharmaceutical Product Development (United States)Milliman (United States)
MI

About

Mirza I. Rahman is an author at Ortho Clinical Diagnostics (United States) specializing in medicine, pharmacotherapy, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

262

2

Public Health

1

1

143

3

Gastroenterology

1

1

17

4

Health Policy

1

1

143

5

Pathology

1

1

143

Mirza I. Rahman

×

10

Publications

433

Citations

10

H-Index

YearCitations

Association between coronary heart disease and cancers of the breast, prostate, and colon.

Alfred I. Neugut, David J. Rosenberg, Habibul Ahsan,

PubMed

1998

143

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis

Boxiong Tang, Mirza I. Rahman, Heidi C. Waters,

Clinical Therapeutics

2008

102

Effects of fistula on healthcare costs and utilization for patients with Crohnʼs disease treated in a managed care environment

Russell D. Cohen, Heidi C. Waters, Boxiong Tang,

Inflammatory Bowel Diseases

2008

43

Administrative Claims Analysis of All-Cause Annual Costs of Care and Resource Utilization by Age Category for Ulcerative Colitis Patients

Stephen J. Bickston, Heidi C. Waters, Omar Dabbous,

Journal of Managed Care Pharmacy

2008

41

A claims‐based Markov model for Crohn’s disease

DC Malone, Heidi C. Waters, Jill Van Den Bos,

Alimentary Pharmacology & Therapeutics

2010

21

Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study

Wally Landsberg, Imad Al‐Dakkak, Antonia Coppin-Renz,

Drug Safety

2018

19

Assessing Drug Treatment Preferences of Patients with Crohnʼs Disease

Gary R. Lichtenstein, Heidi C. Waters, Jenna Kelly,

Patient

2010

17

Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease

Alvin Estilo, LaRee Tracy, Carol Matthews,

Clinical Kidney Journal

2022

17

Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study

Alvin Estilo, Linda Mccormick, Mirza I. Rahman

Advances in Therapy

2021

16

Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations

Kavita Nair, Boxiong Tang, Jill Van Den Bos,

Current Medical Research and Opinion

2008

14

Page 1